Published: May 14, 2026
Updated: May 14, 2026

Sickle Cell Disease is an inherited blood disorder that affects haemoglobin, the protein inside red blood cells responsible for carrying oxygen throughout the body. Red blood cells can easily pass through blood vessels since they are typically spherical and flexible.
In sickle cell disease, the cells take on a crescent or "sickle" form and become stiff and sticky. These aberrant cells may obstruct blood flow, resulting in:
Individuals inherit Sickle Cell Disease from their parents via genes. When both parents transmit the sickle cell gene, their offspring will also inherit this Disease.
It is caused by a mutation in the HBB gene, which helps produce haemoglobin. This mutation leads to the formation of abnormal haemoglobin called Haemoglobin S (HbS).
There are two important genetic possibilities:
A person inherits:
This person, known as a "carrier" or someone with sickle cell trait, typically does not have severe symptoms.
A person inherits:
This causes full sickle cell disease. Due to the autosomal recessive inheritance pattern of the illness, a child must receive the sickle cell gene from both parents in order to be affected.
The main reason is malaria. Africa has been affected by malaria for thousands of years. Malaria had a high death rate before modern medicine, particularly in children.
Researchers found that individuals with sickle cell trait, or having just one sickle cell gene, were more likely to survive in areas where malaria is widespread. Compared to those without the characteristic, they had a lower risk of developing severe malaria.
Because of this protection, carriers were able to reproduce, live longer, and transmit the gene to subsequent generations. In regions where malaria was common, the sickle cell gene grew more prevalent over many generations.
In genetics, this is a perfect example of natural selection.
Thousands of years ago in Africa - One person randomly developed a genetic mutation that made some of their red blood cells slightly sickle-shaped. This was purely accidental not planned by nature or the body.
Sub-Saharan Africa had extremely high malaria rates. Malaria killed millions of people especially children before they could reproduce.
When malaria spread across Africa, people without the sickle cell gene were highly vulnerable; many died before they could have children, so their genes slowly disappeared from the population.
But people who carried the sickle cell gene had a natural shield against malaria; they survived, grew up, had children, and passed that protective gene on. Their children did the same, and their children's children too.
Repeat this cycle for hundreds of generations over thousands of years, and the sickle cell gene gradually became common across African populations not because anyone planned it, but simply because carriers lived long enough to pass it on, and non-carriers often didn't.
Other malaria-prone regions like South Asia and the Mediterranean also developed different genetic adaptations to malaria for the same reason â like G6PD deficiency in Mediterranean populations.
Genotype | Malaria risk | Sickle cell disease |
HbA/HbA (normal) | High | No |
HbA/HbS (carrier) | Low | No |
HbS/HbS | Low | Yes â severe |
Researchers believe that sickle haemoglobin-containing red blood cells make it difficult for the malaria parasite to survive.
In sickle cell trait carriers:
Because of this, carriers frequently have some defense against serious malaria infection.
Carriers are still susceptible to malaria despite this protection. It simply lowers the likelihood of serious or deadly illness.
The sickle cell trait has historically aided in the survival of certain populations against malaria; however, it has affected people with the condition negatively.
In a situation in which both parents are carriers of the sickle cell trait, their child can inherit one of the following traits: 25% chance of inheriting SCD (sickle cell disease), 50% chance of being a carrier of the sickle cell trait, or there is a 25% chance of inheriting normal genes (neither SCD nor carrier).
Therefore, as the sickle cell trait became common amongst the areas affected by malaria, the incidence of children being born with SCD also increased. Very high carrier prevalence continues to exist in many countries in Africa.
The WHO (World Health Organisation) Regional Office for Africa indicates that the carrier prevalence for several countries (e.g., Nigeria, Ghana, Cameroon and Congo) remains at approximately 20 - 30%, whereas some regions of Uganda are exceeding 45%.
Sickle cell disease is especially common in:
Nigeria has one of the highest numbers of sickle cell births globally.
Due to the sickle cell trait's historical survival benefit, the disorder is more prevalent in tropical and malaria-prone areas.
Sickle cell illness is still misdiagnosed in some communities. Some people mistakenly think that poor luck, supernatural attacks, or curses are to blame.
According to science, sickle cell disease is entirely inherited.
Due to genes acquired from both parents, a kid is born with the illness. It is not communicable and cannot be spread by:
Reducing stigma and discrimination in African communities requires raising awareness and educating the public.
Awareness and premarital genetic testing can assist in reducing the prevalence of this disease. In many African nations, couples are encouraged to determine their genotype prior to marriage. The three main genotypes are as follows:
If both partners are *AS*, then they are at an increased risk for having children with this Disease, so genetic counselling may be of benefit to the couple for providing information about these risks and assisting them in making informed decisions for family planning.
Genetically, the disease itself cannot usually be prevented, but with early detection and appropriate treatment, complications and fatalities can be decreased.
Crucial actions consist of:
Early diagnosis and better access to healthcare can greatly increase survival and quality of life, according to the WHO.
There is growing awareness about sickle cell disease across Africa. Many governments, hospitals, NGOs, and advocacy groups are improving:
Research into gene therapy and advanced treatments also offers hope for the future. However, access remains limited in many African regions.
This disease became common in Africa because of genetics and malaria. The sickle cell trait helped protect generations of people from severe malaria, allowing the gene to survive and spread over time.
While this evolutionary advantage helped many communities survive malaria, it also increased the number of children born with sickle cell disease.
Today, education, genotype testing, early diagnosis, and better healthcare can help African families manage and reduce the burden of this disease. Understanding the genetics behind the condition is an important step toward ending stigma and improving lives.
It is common in Africa because of its historical link to malaria. People who carry one sickle cell gene (sickle cell trait) have a natural protection against severe malaria, which allowed them to survive and pass the gene to future generations. Over thousands of years, this made the sickle cell gene increasingly common across malaria-prone regions of Africa.
If both parents carry the sickle cell trait (AS genotype), each pregnancy carries a 25% chance the child will have sickle cell disease (SS), a 50% chance the child will be a carrier (AS), and a 25% chance the child will inherit normal genes (AA). Genetic counselling is strongly recommended for such couples before starting a family.
It cannot currently be prevented through genetics alone, but its impact can be significantly reduced through newborn screening, vaccinations, regular medical check-ups, and medications like hydroxyurea. Premarital genotype testing is strongly encouraged across Africa to help couples make informed family planning decisions. Emerging gene therapy treatments also offer hope for a future cure.
The most reliable way is through a newborn screening test done shortly after birth. If missed, watch for warning signs like unexplained pain, swollen hands and feet, frequent infections, and fatigue. Ask your doctor for a haemoglobin electrophoresis test â this confirms whether your child has the disease, carries the trait, or is completely unaffected.

Dr. Shagufta Parveen is a medical and scientific content writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad. During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources. Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.

Dr. Vishwas Kaushik, an accomplished Belgorod State University graduate with an MBBS, is known for his impactful contributions to healthcare. Driven by a passion for global well-being, he seamlessly led domestic operations at VMV Group of Companies and orchestrated success at Clear Medi Cancer Centre. His adept team management and operational skills have positioned him as a luminary in healthcare tourism, shaping a future where compassionate, world-class medical care knows no boundaries.





Delhi, India

Istanbul, Turkey

Istanbul, Turkey

Istanbul, Turkey